Market Research Logo

Anti-Parkinson's Drugs: Global Markets to 2022

Anti-Parkinson's Drugs: Global Markets to 2022

Report Scope:

This research report categorizes the anti-Parkinson’s drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications.

Report Includes:

- 95 data tables
- An overview of the global market for anti-Parkinson’s drugs and their future demand
- Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease
- Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications
- Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Anti-Parkinson's Drugs Market Characteristics
Chapter 4 Anti-Parkinson's Drugs Market Size and Growth
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
Chapter 5 Anti-Parkinson's Drugs Market Trends and Strategies
New Medication to Help the Body Absorb Parkinson’s Disease Medication
Free Water Biomarker to Track Changes in Brain
3D Printing Technology
Chapter 6 PESTLE Analysis
Political
Government Financial Support
Uncertain Political Policies
Government Intervention
Economic
Wealth
Globalization
Emerging Markets
Social
Aging Global Population
Health Consciousness and Awareness
Traditional Medicine Continues to Pose Threat to Market
Shortage of Skill
Technological
Technological Breakthroughs
Wearable Technology and Hardware Advancements
Internet Penetration and Mobile Applications
Legal
Stringent Regulations and Long Approval Procedures
Tax Exemptions Initiatives and Subsidies
Investment Regulations
Environmental
Chapter 7 Anti-Parkinson's Drugs Market Segmentation
Global Anti-Parkinson's Drugs Market, by Segment
Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Dopaminergics Market
Market Characteristics
Market Trends and Strategies
Dopamine Agonists Market
Market Characteristics
Market Trends and Strategies
Enzyme Inhibitors Market
Market Characteristics
Market Trends and Strategies
Other Anti-Parkinson's Medications Market
Market Characteristics
Chapter 8 Anti-Parkinson's Drugs Market Regional and Country Analysis
Global Anti-Parkinson's Drugs Market, by Region
Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
Global Anti-Parkinson's Drugs Market, by Country
Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country
Chapter 9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors
Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country
Chapter 10 Asia-Pacific Anti-Parkinson's Drugs Market
Asia-Pacific Anti-Parkinson's Drugs Market Overview
Region Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Export and Import Duties on Anti-Parkinson Drugs
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment
Chapter 11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis
China Anti-Parkinson's Drugs Market Overview
Country Information
Market information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and development Projects
Regulatory Bodies
Regulations
Major Associations
Export and Import Duties on Anti-Parkinson Drugs
Taxes Levied
Corporate Tax Structure
Competitive Landscape
China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
China Market Size, by Segment
China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
India Anti-Parkinson's Drugs Market Overview
Country Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties
Taxes Levied
Corporate Tax Structure
Competitive Landscape
India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
India Market Size, by Segment
India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Japan Anti-Parkinson's Drugs Market Overview
Country Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Import and Export Duties on Anti-Parkinson Drugs
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
Japan Market Size, by Segment
Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Australia Anti-Parkinson's Drugs Market
Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
Australia Market Size, by Segment
Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Chapter 12 Western Europe Anti-Parkinson's Drugs Market
Western European Anti-Parkinson's Drugs Market Overview
Region Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
Western Europe Market Size, by Segment
Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Chapter 13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis
UK Anti-Parkinson's Drugs Market Overview
Country Information
Market information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Export and Import Duties on Anti-Parkinson Drugs
Taxes Levied
Corporate Tax Structure
Competitive Landscape
UK Anti-Parkinson's Drugs Historic Market, 2013-2017
UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
UK Market Size, by Segment
UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Germany Anti-Parkinson's Drugs Market
Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
Germany Market Size, by Segment
Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
France Anti-Parkinson's Drugs Market
France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
France Anti-Parkinson's Drugs Forecast Market, 2017-2022
France Market Size, by Segment
France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Italy Anti-Parkinson's Drugs Market
Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
Italy Market Size, by Segment
Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
Spain Anti-Parkinson's Drugs Market
Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
Spain Market Size, by Segment
Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Chapter 14 Eastern Europe Anti-Parkinson's Drugs Market
Eastern European Anti-Parkinson's Drugs Market Overview
Region Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Export and Import Duties On Anti-Parkinson Drugs
Taxes Levied
Corporate Tax Structure
Competitive Landscape
Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
Eastern Europe Market Size, by Segment
Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Chapter 15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis
Russia Anti-Parkinson's Drugs Market
Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
Russia Market Size, by Segment
Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Chapter 16 North America Anti-Parkinson's Drugs Market
North America Anti-Parkinson's Drugs Market Overview
Region Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
North America Anti-Parkinson's Drugs Historic Market, 2013-2017
North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
North America Market Size, by Segment
North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
Chapter 17 North America Anti-Parkinson's Drugs Market: Country Analysis
USA Anti-Parkinson's Drugs Market
USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
USA Market Size, by Segment
USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
Chapter 18 South America Anti-Parkinson's Drugs Market
South America Anti-Parkinson's Drugs Market Overview
Region Information
Market Information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulatory Bodies
Regulations
Major Associations
Taxes Levied
Corporate Tax Structure
Competitive Landscape
South America Anti-Parkinson's Drugs Historic Market, 2013-2017
South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
South America Market Size, by Segment
South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
Chapter 19 South America Anti-Parkinson's Drugs Market: Country Analysis
Brazil Anti-Parkinson's Drugs Market
Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
Brazil Market Size, by Segment
Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
Chapter 20 Middle East Anti-Parkinson's Drugs Market
Middle Anti-Parkinson's Drugs Market Overview
Region Information
Market information
Prevalence of Parkinson's Disease
Government Initiatives
Major Contracts/Research and Development Projects
Regulations
Regulatory Bodies
Major Associations
Competitive Landscape
Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
Middle East Market Size, by Segment
Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
Chapter 21 Africa Anti-Parkinson's Drugs Market
Africa Anti-Parkinson's Drugs Market Overview
Region Information
Market information
Prevalence of Parkinson's Disease
Government Initiatives
Regulatory Bodies
Major Associations
Export and Import Duties on Anti-Parkinson Drugs
Competitive Landscape
Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
Africa Market Size, by Segment
Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
Chapter 22 Anti-Parkinson's Drugs Market Customer Information
Significant Impact of Parkinson's Disease on Quality of Life
Knowledge Gaps among Parkinson's Patients and Caregivers
Parkinson's Awareness in UK
Knowledge on Parkinson's Disease among Patients and General Neurologists
Power of Placebo
Chapter 23 Anti-Parkinson's Drugs Market Competitive Landscape
Company Profiles
ABBVIE
BOEHRINGER INGELHEIM
F. HOFFMANN-LA ROCHE AG
NOVARTIS AG
UCB SA
Chapter 24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market
Teva Pharmaceutical Acquired Auspex Pharmaceuticals
Mitsubishi Tanabe Acquired NeuroDerm
Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
Acorda Therapeutics Acquired Civitas Therapeutics
Acorda Therapeutics Acquired Biotie Therapies
Chapter 25 Appendix
Definitions of the Industry
Anti-Parkinson's Drugs
Research Methodology
Chapter 26 References
List of Tables
Summary Table : Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 1 : Global Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 2 : Global Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 3 : Global Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 4 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 5 : Global Anti-Parkinson’s Drugs Market, by Region, 2017
Table 6 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Table 7 : Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017
Table 8 : Global Anti-Parkinson’s Drugs Market, by Country, 2017
Table 9 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Table 10 : Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Table 11 : Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013–2022
Table 12 : Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, by Country, 2017
Table 13 : Asia-Pacific-Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 14 : Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 15 : Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 16 : Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 17 : China Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 18 : China Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 19 : China Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 20 : China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 21 : India Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 22 : India Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 23 : India Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 24 : India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 25 : Japan Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 26 : Japan Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 27 : Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 28 : Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 29 : Australia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 30 : Australia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 31 : Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 32 : Australia Anti-Parkinson’s Drugs Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 33 : Western Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 34 : Western Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 35 : Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 36 : Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 37 : UK Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 38 : UK Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 39 : UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 40 : UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 41 : Germany Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 42 : Germany Anti-Parkinson’s Drugs Forecast Market, Through 2022,
Table 43 : Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 44 : Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 45 : France Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 46 : France Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 47 : France Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 48 : France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 49 : Italy Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 50 : Italy Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 51 : Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 52 : Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 53 : Spain Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 54 : Spain Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 55 : Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 56 : Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 57 : Eastern Europe Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 58 : Eastern Europe Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 59 : Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 60 : Eastern Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 61 : Russia Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 62 : Russia Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 63 : Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 64 : Russia Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 65 : North America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 66 : North America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 67 : North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 68 : North America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 69 : USA Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 70 : USA Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 71 : USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 72 : USA Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 73 : South America Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 74 : South America Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 75 : South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 76 : South America Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 77 : Brazil Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 78 : Brazil Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 79 : Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 80 : Brazil Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 81 : Middle East Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 82 : Middle East Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 83 : Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 84 : Middle East Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 85 : Africa Anti-Parkinson’s Drugs Historic Market, Through 2017
Table 86 : Africa Anti-Parkinson’s Drugs Forecast Market, Through 2022
Table 87 : Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Table 88 : Africa Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 89 : Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017
Table 90 : AbbVie, Inc.: Financial Performance, 2013-2017
Table 91 : Boehringer Ingelheim: Financial Performance, 2013-2016
Table 92 : F. Hoffmann-La Roche: Financial Performance, 2013-2017
Table 93 : Novartis AG: Financial Performance, 2013-2017
Table 94 : UCB SA: Financial Performance, 2013-2017
Table 95 : Market Data Sources
List of Figures
Summary Figure : Global Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 1 : Global Anti-Parkinson's Drugs Historic Market, 2013-2017
Figure 2 : Global Anti-Parkinson's Drugs Forecast Market, 2017-2022
Figure 3 : PESTLE Analysis: Global Anti-Parkinson’s Drugs Market, 2017
Figure 4 : Global Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 5 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 6 : Global Anti-Parkinson’s Drugs Market Share, by Region, 2017
Figure 7 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 8 : Global Anti-Parkinson’s Drugs Market Segmentation, by Region, 2017,
Figure 9 : Global Anti-Parkinson’s Drugs Market Share, by Country, 2017
Figure 10 : Global Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 11 : Global Anti-Parkinson’s Drugs Market Segmentation, by Country, 2017
Figure 12 : Global Per Capita Average Anti-Parkinson’s Drugs Market Expenditure, 2013–2022
Figure 13 : Asia-Pacific Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 14 : Asia-Pacific Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 15 : Asia-Pacific Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 16 : Asia-Pacific Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 17 : China Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 18 : China Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 19 : China Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 20 : China Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 21 : India Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 22 : India Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 23 : India Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 24 : India Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 25 : Japan Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 26 : Japan Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 27 : Japan Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 28 : Japan Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 29 : Australia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 30 : Australia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 31 : Australia Anti-Parkinson’s Drugs Market Share, by Segment, 2017
Figure 32 : Australia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 33 : Western Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 34 : Western Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 35 : Western Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 36 : Western Europe Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 37 : UK Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 38 : UK Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 39 : UK Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 40 : UK Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 41 : Germany Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 42 : Germany Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 43 : Germany Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 44 : Germany Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 45 : France Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 46 : France Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 47 : France Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 48 : France Anti-Parkinson’s Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49 : Italy Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 50 : Italy Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 51 : Italy Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 52 : Italy Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 53 : Spain Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 54 : Spain Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 55 : Spain Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 56 : Spain Anti-Parkinson’s Drugs Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 57 : Eastern Europe Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 58 : Eastern Europe Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 59 : Eastern Europe Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 60 : Eastern Europe Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 61 : Russia Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 62 : Russia Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 63 : Russia Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 64 : Russia Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 65 : North America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 66 : North America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 67 : North America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 68 : North America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 69 : USA Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 70 : USA Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 71 : USA Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 72 : USA Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 73 : South America Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 74 : South America Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 75 : South America Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 76 : South America Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 77 : Brazil Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 78 : Brazil Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 79 : Brazil Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 80 : Brazil Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 81 : Middle East Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 82 : Middle East Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 83 : Middle East Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 84 : Middle East Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 85 : Africa Anti-Parkinson’s Drugs Historic Market, 2013-2017
Figure 86 : Africa Anti-Parkinson’s Drugs Forecast Market, 2017-2022
Figure 87 : Africa Anti-Parkinson’s Drugs Market, by Segment, 2017
Figure 88 : Africa Anti-Parkinson’s Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 89 : Global Market Share for Key Competitors of Anti-Parkinson’s Drugs, 2017,
Figure 90 : AbbVie Inc.: Financial Performance, 2013-2017
Figure 91 : Boehringer Ingelheim: Financial Performance, 2013-2016
Figure 92 : F. Hoffmann-La Roche: Financial Performance, 2013-2017
Figure 93 : Novartis AG: Financial Performance, 2013-2017
Figure 94 : UCB SA: Financial Performance, 2013-2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report